Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple

Cornelia Buerger1, Nele Plock, Pejman Dehghanyar

  • 1Department of Clinical Pharmacy, Institute of Pharmacy, Freie Universitaet Berlin, D-12169 Berlin, Germany.

Insights

Linezolid effectively distributes into interstitial fluid in critically ill patients, but high variability suggests personalized dosing may be needed for optimal treatment of severe infections.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Linezolid is crucial for treating severe infections, including those caused by methicillin-resistant Staphylococcus strains.
  • Understanding linezolid's penetration into tissue interstitial fluid is vital for optimizing therapy in critically ill patients.

Purpose of the Study:

  • To evaluate linezolid penetration into subcutaneous adipose tissue and skeletal muscle interstitial space fluid (ISF) in patients with sepsis or septic shock.
  • To determine unbound linezolid concentrations in plasma and ISF using microdialysis and pharmacokinetic analysis.

Main Methods:

  • A microdialysis study was conducted with 12 critically ill patients receiving multiple intravenous linezolid infusions.
  • Unbound linezolid concentrations were measured in plasma and ISF via high-performance liquid chromatography.
  • Individual and integrated pharmacokinetic (PK) modeling was performed using WinNonlin.

Main Results:

  • In vivo microdialysis successfully determined steady-state unbound linezolid concentrations in ISF.
  • Linezolid demonstrated good ISF distribution, but with significant interindividual variability.
  • A two-compartment model showed a mean distribution volume of 62.9 L and clearance of 9.18 L/h, with intraindividual changes over time.

Conclusions:

  • Current linezolid dosing may require adjustments for some critically ill patients to maintain effective concentrations in infected tissues.
  • An integrated PK model provides a foundation for developing refined dosing guidelines using a population PK approach.
  • Personalized dosing strategies are essential to ensure effective antimicrobial therapy and avoid subinhibitory concentrations in diverse patient populations.

Related Concept Videos

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...